FEB 10, 2020 6:24 PM PST

Drug Prevents Coronavirus in Monkeys

WRITTEN BY: Nouran Amin

An antiviral drug successfully prevented Middle East respiratory syndrome coronavirus (MERS-CoV) in infected rhesus macaques. The drug, Remdesivir, was administered in the macaques before infection and improved their condition after infection. These findings are according to a new report from the NIH's National Institute of Allergy and Infectious Diseases (NIAID) and is published in the Proceedings of the National Academy of Sciences.

Learn more about the coronavirus:

MERS-CoV is similar to the 2019 novel coronavirus (SARS-CoV-2) that first emerged as a public health crisis in Wuhan, China. Previous studies observed the protection of animals against a variety of viral infections due to Remdesivir administration. Now, it was shown to experimentally treat monkeys with Ebola and Nipah viruses.

The present study investigated animals for six days that were 1) treated with remdesivir 24 hours before infection with MERS-CoV 2) those treated 12 hours after infection and 3) untreated control animals that showed signs of respiratory disease. The pre-infection animals had no signs of respiratory disease and no lung damage along with low levels of virus replication in the lungs in comparison to the control animals. For animals treated after infection, symptoms of the disease were less severe than in control animals.

The promising findings of the study encourage researches to push for clinical trials of remdesivir for MERS-CoV and COVID-19, the disease that SARS-CoV-2 causes. In fact, several studies for clinical trials of remdesivir for COVID-19 are under way in China, and other patients with COVID-19 have received the drug under a compassionate use protocol.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUN 24, 2020
Drug Discovery & Development
Gilead to Test Inhalable Remdesivir Against COVID-19
JUN 24, 2020
Gilead to Test Inhalable Remdesivir Against COVID-19
Gilead has announced that it will soon start trials for an inhalable form of Remdesivir, the first drug to receive Emerg ...
JUN 29, 2020
Drug Discovery & Development
Staring into Deep Red Light Improves Eyesight
JUN 29, 2020
Staring into Deep Red Light Improves Eyesight
Researchers from UCL have found that staring into a deep red light for just three minutes per day can significantly impr ...
JUL 05, 2020
Drug Discovery & Development
New Drug May Reduce Inflammation from COVID-19
JUL 05, 2020
New Drug May Reduce Inflammation from COVID-19
Scientists from the University of Toronto have identified a new drug candidate that may reduce all kinds of inflammation ...
JUL 17, 2020
Immunology
More Potential Antibody Therapies for COVID Emerge
JUL 17, 2020
More Potential Antibody Therapies for COVID Emerge
When it comes to clinical countermeasures against COVID-19, one class of molecules stands out among the others: antibodi ...
JUL 19, 2020
Drug Discovery & Development
Synapse-Saving Proteins Could Stave Off Alzheimer's
JUL 19, 2020
Synapse-Saving Proteins Could Stave Off Alzheimer's
Researchers at the University of Texas have identified a new subset of proteins capable of protecting synapses- the stru ...
AUG 04, 2020
Drug Discovery & Development
Erectile Dysfunction Drug Cures Critical COVID-19 Patients
AUG 04, 2020
Erectile Dysfunction Drug Cures Critical COVID-19 Patients
Critically ill patients who received COVID-19 drug candidate aviptadil (RLF-100) were able to make a rapid recovery from ...
Loading Comments...